These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15030527)

  • 1. Cathepsin D is up-regulated in inflammatory bowel disease macrophages.
    Hausmann M; Obermeier F; Schreiter K; Spottl T; Falk W; Schölmerich J; Herfarth H; Saftig P; Rogler G
    Clin Exp Immunol; 2004 Apr; 136(1):157-67. PubMed ID: 15030527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoprotein (gp) 96 expression: induced during differentiation of intestinal macrophages but impaired in Crohn's disease.
    Schreiter K; Hausmann M; Spoettl T; Strauch UG; Bataille F; Schoelmerich J; Herfarth H; Falk W; Rogler G
    Gut; 2005 Jul; 54(7):935-43. PubMed ID: 15951537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo.
    Menzel K; Hausmann M; Obermeier F; Schreiter K; Dunger N; Bataille F; Falk W; Scholmerich J; Herfarth H; Rogler G
    Clin Exp Immunol; 2006 Oct; 146(1):169-80. PubMed ID: 16968411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of inducible nitric oxide synthase (iNOS) mRNA in inflamed esophageal and colonic mucosa in a pediatric population.
    Gupta SK; Fitzgerald JF; Chong SK; Croffie JM; Garcia JG
    Am J Gastroenterol; 1998 May; 93(5):795-8. PubMed ID: 9625130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease.
    Kruidenier L; Kuiper I; van Duijn W; Marklund SL; van Hogezand RA; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):7-16. PubMed ID: 12950012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistry.
    ter Beek WP; Biemond I; Muller ES; van den Berg M; Lamers CB
    Neuropeptides; 2007 Oct; 41(5):301-6. PubMed ID: 17602742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice.
    Bamba S; Lee CY; Brittan M; Preston SL; Direkze NC; Poulsom R; Alison MR; Wright NA; Otto WR
    J Pathol; 2006 Jun; 209(2):265-73. PubMed ID: 16550633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of the ubiquitin-proteasome system in normal colonic macrophages and reinduction in inflammatory bowel disease.
    Hetzenecker AM; Seidl MC; Kosovac K; Herfarth H; Kellermeier S; Obermeier F; Falk W; Schoelmerich J; Hausmann M; Rogler G
    Digestion; 2012; 86(1):34-47. PubMed ID: 22710419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease.
    Renner M; Bergmann G; Krebs I; End C; Lyer S; Hilberg F; Helmke B; Gassler N; Autschbach F; Bikker F; Strobel-Freidekind O; Gronert-Sum S; Benner A; Blaich S; Wittig R; Hudler M; Ligtenberg AJ; Madsen J; Holmskov U; Annese V; Latiano A; Schirmacher P; Amerongen AV; D'Amato M; Kioschis P; Hafner M; Poustka A; Mollenhauer J
    Gastroenterology; 2007 Nov; 133(5):1499-509. PubMed ID: 17983803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
    Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease.
    Kruidenier L; Kuiper I; Van Duijn W; Mieremet-Ooms MA; van Hogezand RA; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):17-27. PubMed ID: 12950013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer.
    Krueger S; Kalinski T; Hundertmark T; Wex T; Küster D; Peitz U; Ebert M; Nägler DK; Kellner U; Malfertheiner P; Naumann M; Röcken C; Roessner A
    J Pathol; 2005 Sep; 207(1):32-42. PubMed ID: 16025436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine.
    Klebl FH; Olsen JE; Jain S; Doe WF
    J Pathol; 2001 Dec; 195(5):609-15. PubMed ID: 11745698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtractive screening reveals up-regulation of NADPH oxidase expression in Crohn's disease intestinal macrophages.
    Hausmann M; Spöttl T; Andus T; Rothe G; Falk W; Schölmerich J; Herfarth H; Rogler G
    Clin Exp Immunol; 2001 Jul; 125(1):48-55. PubMed ID: 11472425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of cytokine mRNA expression in intestinal biopsies of cats with inflammatory enteropathy using quantitative real-time RT-PCR.
    Nguyen Van N; Taglinger K; Helps CR; Tasker S; Gruffydd-Jones TJ; Day MJ
    Vet Immunol Immunopathol; 2006 Oct; 113(3-4):404-14. PubMed ID: 16879876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of inflammatory bowel disease in a mouse model of depression.
    Ghia JE; Blennerhassett P; Deng Y; Verdu EF; Khan WI; Collins SM
    Gastroenterology; 2009 Jun; 136(7):2280-2288.e1-4. PubMed ID: 19272381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel anti-inflammatory action of 5-aminoimidazole-4-carboxamide ribonucleoside with protective effect in dextran sulfate sodium-induced acute and chronic colitis.
    Bai A; Yong M; Ma AG; Ma Y; Weiss CR; Guan Q; Bernstein CN; Peng Z
    J Pharmacol Exp Ther; 2010 Jun; 333(3):717-25. PubMed ID: 20237071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase A2 activating protein and idiopathic inflammatory bowel disease.
    Peterson JW; Dickey WD; Saini SS; Gourley W; Klimpel GR; Chopra AK
    Gut; 1996 Nov; 39(5):698-704. PubMed ID: 9014769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
    Araki A; Kanai T; Ishikura T; Makita S; Uraushihara K; Iiyama R; Totsuka T; Takeda K; Akira S; Watanabe M
    J Gastroenterol; 2005 Jan; 40(1):16-23. PubMed ID: 15692785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.